Program Detail

Program Detail

Modality
Program #
Program indication
Presentation
mRNA-1777

Source
Respiratory syncytial virus (RSV) vaccine

mRNA-1777
Last updated Dec 06, 2018
mRNA-1647

Source
Cytomegalovirus (CMV) vaccine

mRNA-1647
Last updated Dec 06, 2018
mRNA-1653

Source
Human metapneumovirus and \nparainfluenza virus 3 (hMPV+PIV3) vaccine

mRNA-1653
Last updated Dec 06, 2018
mRNA-1278

Source
Varicella zoster virus \n\i(VZV) vaccine/i

mRNA-1278
Last updated Dec 06, 2018
mRNA-1440

Source
Influenza H10N8 vaccine

mRNA-1440
Last updated Dec 06, 2018
mRNA-1851

Source
Influenza H7N9 vaccine

mRNA-1851
Last updated Dec 06, 2018
mRNA-1325*

Source
Zika vaccine

mRNA-1325*
Last updated Dec 06, 2018
mRNA-1893

Source
Zika vaccine

mRNA-1893
Last updated Dec 06, 2018
mRNA-1388

Source
Chikungunya vaccine

mRNA-1388
Last updated Dec 06, 2018
mRNA-4157 \nNCI-4650

Source
Personalized Cancer Vaccine (PCV) \n\iSolid tumors/i

mRNA-4157 \nNCI-4650
Last updated Dec 06, 2018
mRNA-5671

Source
KRAS vaccine \n\iCRC, NSCLC, pancreatic cancer/i

mRNA-5671
Last updated Dec 06, 2018
mRNA-2416

Source
OX40L \n\iSolid tumors/lymphoma/i\n\iAdvanced ovarian carcinoma/i

mRNA-2416
Last updated Jan 08, 2019
mRNA-2752

Source
OX40L+IL23+IL36γ \n\iSolid tumors/lymphoma/i

mRNA-2752
Last updated Jan 08, 2019
MEDI1191

Source
IL12 \n\iSolid tumors/i

MEDI1191
Last updated Dec 06, 2018
AZD8601

Source
VEGF-A \n\iMyocardial ischemia/i

AZD8601
Last updated Dec 06, 2018
mRNA-1944

Source
Antibody against Chikungunya virus

mRNA-1944
Last updated Dec 06, 2018
AZD7970

Source
Relaxin \n\iHeart failure/i

AZD7970
Last updated Dec 06, 2018
mRNA-3630

Source
α-GAL \n\iFabry disease/i

mRNA-3630
Last updated Dec 06, 2018
mRNA-3704

Source
MUT \n\iMethylmalonic acidemia (MMA)/i

mRNA-3704
Last updated Jan 08, 2019
mRNA-3927

Source
PCCA+PCCB \n\iPropionic acidemia (PA)/i

mRNA-3927
Last updated Dec 06, 2018
mRNA-3283

Source
PAH \n\iPhenylketonuria (PKU)/i

mRNA-3283
Last updated Dec 06, 2018